Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Becton Dickinson and Co (BDX) vs Unilever plc (UL) Price & Performance

Becton Dickinson and CoTrade
Unilever plcTrade

Price performance (Past 24H)

Key statistics

Becton Dickinson and Co vs Unilever plc — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Unilever plc trades at $62.32 (market cap $134.76B). The key difference: Unilever plc is far larger — about 2.8× Becton Dickinson and Co's market cap, and Unilever plc pays the higher dividend (3.63%). Which is the better fit depends on your goals.

BDXUL
Market Cap
$48.93B$134.76B
Sector
HealthConsumer Staples
52-Week High
$185.39$74.59
52-Week Low
$138.62$55.05
Enterprise Value
$65.03B$160.58B
Dividend Yield
2.34%3.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Becton Dickinson and Co

BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.

The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.

Unilever plc

Unilever (UL) trades at $62.96, down 1.1% over 24 hours, with technical indicators showing a bullish trend and strong support at $62. The company reported $50.5B revenue in 2025 with a net income margin of 18.75%, though recent quarters saw earnings misses. Positive sentiment is driven by a potential merger with McCormick and strong Q2 2026 volume growth, while analyst consensus is mixed with 24% buy ratings.

The outlook is cautiously optimistic due to merger synergies and margin expansion potential, but risks include integration challenges and competitive pressures. Cash flow volatility and debt levels warrant monitoring. The stock presents a value opportunity if execution improves, but near-term volatility may persist amid macroeconomic uncertainties.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX

About Unilever plc

Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years

Read more on UL